In an elderly woman with diabetes, insulin was discontinued after dulaglutide and repaglinide treatment during recovery from glucotoxicity.
In plain wordsAn elderly woman stopped insulin after dulaglutide and repaglinide treatment during recovery from high blood sugar.
- Peptide
- Dulaglutide (Trulicity)
- Outcome
- DecreaseInsulin discontinuation
- Study
n = 1
- Outcome group
- Glycemic control · Metabolic and weight
Measurements
- Peak insulin dose before discontinuation
- 23 units/day
- single case before insulin was stopped
Source sentences
After initiating dulaglutide and repaglinide treatment, insulin therapy, which peaked at 23 units/day, was discontinued.
2 context sentences(design, population, supporting numbers)
An 82-year-old woman with an impaired consciousness presented to our hospital.
She was diagnosed with diabetic ketoacidosis and cellulitis and was admitted to the hospital.
In this study, Dulaglutide (Trulicity) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Dulaglutide (Trulicity).